JP2024129140A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024129140A5 JP2024129140A5 JP2024108997A JP2024108997A JP2024129140A5 JP 2024129140 A5 JP2024129140 A5 JP 2024129140A5 JP 2024108997 A JP2024108997 A JP 2024108997A JP 2024108997 A JP2024108997 A JP 2024108997A JP 2024129140 A5 JP2024129140 A5 JP 2024129140A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- pharmaceutical composition
- fev
- asthma
- weeks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361864948P | 2013-08-12 | 2013-08-12 | |
| US61/864,948 | 2013-08-12 | ||
| JP2020067766A JP2020125304A (ja) | 2013-08-12 | 2020-04-03 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
| JP2022092222A JP2022120010A (ja) | 2013-08-12 | 2022-06-07 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022092222A Division JP2022120010A (ja) | 2013-08-12 | 2022-06-07 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026080771A Division JP2026130002A (ja) | 2013-08-12 | 2026-05-13 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024129140A JP2024129140A (ja) | 2024-09-26 |
| JP2024129140A5 true JP2024129140A5 (enExample) | 2025-08-05 |
| JP7864776B2 JP7864776B2 (ja) | 2026-05-25 |
Family
ID=52448838
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016534615A Active JP6746496B2 (ja) | 2013-08-12 | 2014-08-07 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
| JP2020067766A Withdrawn JP2020125304A (ja) | 2013-08-12 | 2020-04-03 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
| JP2022092222A Pending JP2022120010A (ja) | 2013-08-12 | 2022-06-07 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
| JP2024108997A Active JP7864776B2 (ja) | 2013-08-12 | 2024-07-05 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016534615A Active JP6746496B2 (ja) | 2013-08-12 | 2014-08-07 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
| JP2020067766A Withdrawn JP2020125304A (ja) | 2013-08-12 | 2020-04-03 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
| JP2022092222A Pending JP2022120010A (ja) | 2013-08-12 | 2022-06-07 | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US9441046B2 (enExample) |
| EP (5) | EP3033104B1 (enExample) |
| JP (4) | JP6746496B2 (enExample) |
| KR (1) | KR102337599B1 (enExample) |
| CN (2) | CN105451769A (enExample) |
| AU (2) | AU2014306959B2 (enExample) |
| BR (1) | BR112016002317A8 (enExample) |
| CA (1) | CA2917603C (enExample) |
| CY (2) | CY1122033T1 (enExample) |
| DK (2) | DK3520811T3 (enExample) |
| ES (2) | ES2866426T3 (enExample) |
| HK (1) | HK1222559A1 (enExample) |
| HR (2) | HRP20190920T1 (enExample) |
| HU (2) | HUE053627T2 (enExample) |
| LT (2) | LT3033104T (enExample) |
| ME (1) | ME03403B (enExample) |
| MX (2) | MX381102B (enExample) |
| PL (2) | PL3520811T3 (enExample) |
| PT (2) | PT3033104T (enExample) |
| RS (2) | RS58711B1 (enExample) |
| RU (1) | RU2703568C2 (enExample) |
| SG (1) | SG11201600483QA (enExample) |
| SI (2) | SI3520811T1 (enExample) |
| SM (2) | SMT201900311T1 (enExample) |
| TR (1) | TR201907907T4 (enExample) |
| WO (1) | WO2015023507A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2918105C (en) * | 2013-08-12 | 2023-02-28 | Medimmune, Llc | Methods for reducing exacerbation rates of asthma using benralizumab |
| BR112016002462A8 (pt) * | 2013-08-12 | 2018-06-12 | Medimmune Llc | Métodos para melhorar os sintomas da asma usando benralizumabe |
| SG10201807318RA (en) * | 2013-10-15 | 2018-09-27 | Astrazeneca Ab | Methods for treating chronic obstructive pulmonary disease using benralizumab |
| LT3060229T (lt) * | 2013-10-24 | 2021-09-27 | Astrazeneca Ab | Stabilios vandeninės antikūno vaistinės formos |
| TW202110479A (zh) * | 2019-05-16 | 2021-03-16 | 瑞典商阿斯特捷利康公司 | 使用貝那利珠單抗治療增強型患者群體慢性阻塞性肺病之方法 |
| TW202126688A (zh) * | 2019-09-27 | 2021-07-16 | 瑞典商阿斯特捷利康公司 | 使用貝那利珠單抗治療遲發性氣喘之方法 |
| TW202214692A (zh) * | 2020-06-05 | 2022-04-16 | 瑞典商阿斯特捷利康公司 | 治療患有鼻瘜肉的患者的重度氣喘之方法 |
| WO2026053166A1 (en) * | 2024-09-06 | 2026-03-12 | Medimmune Limited | Anti-il5r-alpha treatment for acute exacerbations of asthma and copd |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2233974T3 (es) | 1995-09-11 | 2005-06-16 | Kyowa Hakko Kogyo Co., Ltd. | Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana. |
| US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
| EP2275540B1 (en) | 1999-04-09 | 2016-03-23 | Kyowa Hakko Kirin Co., Ltd. | Method for controlling the activity of immunologically functional molecule |
| WO2001060405A1 (en) | 2000-02-15 | 2001-08-23 | Kyowa Hakko Kogyo Co., Ltd. | Eosinophil-specific apoptosis inducer |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US8093357B2 (en) | 2002-03-01 | 2012-01-10 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
| AU2004279740A1 (en) | 2003-10-08 | 2005-04-21 | Kyowa Hakko Kirin Co., Ltd. | Antibody composition specifically binding to IL-5 receptor |
| US20060014680A1 (en) | 2004-07-13 | 2006-01-19 | Caiding Xu | Peptides and compounds that bind to the IL-5 receptor |
| DK1931709T3 (en) | 2005-10-03 | 2017-03-13 | Xencor Inc | FC VARIETIES WITH OPTIMIZED FC RECEPTOR BINDING PROPERTIES |
| PT3072525T (pt) * | 2007-05-14 | 2018-04-20 | Astrazeneca Ab | Métodos para reduzir os níveis de basófilos |
| RU2383345C1 (ru) * | 2008-08-07 | 2010-03-10 | Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА") | Способ лечения больных бронхиальной астмой |
| KR101615420B1 (ko) * | 2010-12-16 | 2016-04-26 | 제넨테크, 인크. | Th2 억제에 관한 진단 및 치료 |
| CN102544908B (zh) | 2010-12-17 | 2016-01-06 | 富士康(昆山)电脑接插件有限公司 | 电连接器组件及插头连接器 |
| WO2012158954A1 (en) | 2011-05-18 | 2012-11-22 | Medimmune, Llc | Methods of diagnosing and treating pulmonary diseases or disorders |
| CN104039352A (zh) | 2011-11-01 | 2014-09-10 | 米迪缪尼有限公司 | 用于降低哮喘急性恶化的频率和严重性的方法 |
| CA2918105C (en) * | 2013-08-12 | 2023-02-28 | Medimmune, Llc | Methods for reducing exacerbation rates of asthma using benralizumab |
| BR112016002462A8 (pt) * | 2013-08-12 | 2018-06-12 | Medimmune Llc | Métodos para melhorar os sintomas da asma usando benralizumabe |
-
2014
- 2014-08-07 SM SM20190311T patent/SMT201900311T1/it unknown
- 2014-08-07 LT LTEP14836725.3T patent/LT3033104T/lt unknown
- 2014-08-07 WO PCT/US2014/050119 patent/WO2015023507A2/en not_active Ceased
- 2014-08-07 SI SI201431795T patent/SI3520811T1/sl unknown
- 2014-08-07 EP EP14836725.3A patent/EP3033104B1/en active Active
- 2014-08-07 EP EP19158446.5A patent/EP3520811B1/en active Active
- 2014-08-07 SI SI201431191T patent/SI3033104T1/sl unknown
- 2014-08-07 EP EP25191983.3A patent/EP4636400A3/en active Pending
- 2014-08-07 HU HUE19158446A patent/HUE053627T2/hu unknown
- 2014-08-07 ES ES19158446T patent/ES2866426T3/es active Active
- 2014-08-07 PL PL19158446T patent/PL3520811T3/pl unknown
- 2014-08-07 RS RS20190556A patent/RS58711B1/sr unknown
- 2014-08-07 MX MX2016001384A patent/MX381102B/es unknown
- 2014-08-07 EP EP20208316.8A patent/EP3875487A1/en not_active Withdrawn
- 2014-08-07 ES ES14836725T patent/ES2733602T3/es active Active
- 2014-08-07 HK HK16110776.1A patent/HK1222559A1/zh unknown
- 2014-08-07 DK DK19158446.5T patent/DK3520811T3/da active
- 2014-08-07 RS RS20210305A patent/RS61565B1/sr unknown
- 2014-08-07 HR HRP20190920TT patent/HRP20190920T1/hr unknown
- 2014-08-07 AU AU2014306959A patent/AU2014306959B2/en active Active
- 2014-08-07 LT LTEP19158446.5T patent/LT3520811T/lt unknown
- 2014-08-07 TR TR2019/07907T patent/TR201907907T4/tr unknown
- 2014-08-07 CN CN201480045047.8A patent/CN105451769A/zh active Pending
- 2014-08-07 ME MEP-2019-137A patent/ME03403B/me unknown
- 2014-08-07 PT PT14836725T patent/PT3033104T/pt unknown
- 2014-08-07 CA CA2917603A patent/CA2917603C/en active Active
- 2014-08-07 DK DK14836725.3T patent/DK3033104T3/da active
- 2014-08-07 RU RU2016108809A patent/RU2703568C2/ru active
- 2014-08-07 JP JP2016534615A patent/JP6746496B2/ja active Active
- 2014-08-07 HU HUE14836725A patent/HUE043497T2/hu unknown
- 2014-08-07 PL PL14836725T patent/PL3033104T3/pl unknown
- 2014-08-07 BR BR112016002317A patent/BR112016002317A8/pt not_active Application Discontinuation
- 2014-08-07 EP EP25150773.7A patent/EP4579236A3/en not_active Withdrawn
- 2014-08-07 KR KR1020167006576A patent/KR102337599B1/ko active Active
- 2014-08-07 SM SM20210152T patent/SMT202100152T1/it unknown
- 2014-08-07 SG SG11201600483QA patent/SG11201600483QA/en unknown
- 2014-08-07 US US14/454,138 patent/US9441046B2/en active Active
- 2014-08-07 PT PT191584465T patent/PT3520811T/pt unknown
- 2014-08-07 CN CN202010450690.6A patent/CN111588849A/zh active Pending
-
2016
- 2016-01-29 MX MX2021003826A patent/MX2021003826A/es unknown
-
2019
- 2019-07-03 CY CY20191100700T patent/CY1122033T1/el unknown
-
2020
- 2020-02-21 AU AU2020201277A patent/AU2020201277A1/en not_active Abandoned
- 2020-04-03 JP JP2020067766A patent/JP2020125304A/ja not_active Withdrawn
-
2021
- 2021-03-10 HR HRP20210406TT patent/HRP20210406T1/hr unknown
- 2021-03-24 CY CY20211100261T patent/CY1124399T1/el unknown
-
2022
- 2022-06-07 JP JP2022092222A patent/JP2022120010A/ja active Pending
-
2024
- 2024-07-05 JP JP2024108997A patent/JP7864776B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025038127A5 (enExample) | ||
| Tamm et al. | Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice | |
| JP2023052457A5 (enExample) | ||
| CZ219196A3 (en) | Application of mometasonfuorate aqueous suspension for preparing a medicament for effective intranasal treatment of nasal allergy | |
| JP2024074963A5 (enExample) | ||
| JP2015527364A5 (enExample) | ||
| JP2022530533A5 (enExample) | ||
| JP2006502969A (ja) | 内因性性腺刺激ホルモン産生の増強 | |
| JP2013523683A5 (enExample) | ||
| JP2024518947A5 (enExample) | ||
| CN103945849A (zh) | 癌症的联合治疗 | |
| JP2020100630A5 (enExample) | ||
| US8877740B2 (en) | Compound composition for inhalation used for treating asthma | |
| CN120284871B (zh) | 用于鼻腔的含奥洛他定与溴莫尼定的复方制剂组合物及其制备方法 | |
| CN1674907A (zh) | 瑞波西汀在治疗热潮红中的用途 | |
| US20220211674A1 (en) | Thromboxane Receptor Antagonists in AERD/Asthma | |
| JP2024540044A5 (enExample) | ||
| EA009935B1 (ru) | Новая синергетическая комбинация, включающая рофлумиласт и формотерол | |
| WO2003022292A1 (fr) | Formulation pharmaceutique orale contenant du charbon actif et utilisation de cette formulation | |
| JP2022532220A (ja) | ベンラリズマブを使用した強化された患者個体群における慢性閉塞性肺疾患を治療するための方法 | |
| EA009990B1 (ru) | Синергетическая комбинация, включающая рофлумиласт и r,r-формотерол | |
| JP2005518437A (ja) | 自己免疫疾患の治療のための生体エストリオール・スルファミン酸エステル・プロドラックの使用 | |
| WO2025119815A1 (en) | Combination preparation for the treatment of acute and chronic rhinosinusitis and/or allergic rhinitis | |
| WO2022264097A1 (en) | Pharmaceutical composition of anti-tumour necrosis factor (anti-tnf) agent for management of infectious diseases caused by coronaviruses | |
| JP2025501865A5 (enExample) |